Showing 1 - 13 results of 13 for search 'Chul-Gu Kim', query time: 0.04s Refine Results
  1. 1
    Investigation of the Trend of Selecting Anti-Vascular Endothelial Growth Factor Agents for the Initial Treatment of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy

    Investigation of the Trend of Selecting Anti-Vascular Endothelial Growth Factor Agents for the Initial Treatment of Neovascular Age-Related Macular Degeneration and Polypoidal Chor... by Jae-Hui Kim, Jong-Woo Kim, Chul-Gu Kim

    Published 2021-08-01
    Get full text
    Article
  2. 2
    Comparison of 24-month treatment outcomes between as-needed treatment and switching to treat-and-extend in type 3 macular neovascularization

    Comparison of 24-month treatment outcomes between as-needed treatment and switching to treat-and-extend in type 3 macular neovascularization by Jae Hui Kim, Jong Woo Kim, Chul Gu Kim

    Published 2022-12-01
    Get full text
    Article
  3. 3
    Incidence of early complications requiring treatment plan changes after vitreoretinal surgery: a single-center study in South Korea

    Incidence of early complications requiring treatment plan changes after vitreoretinal surgery: a single-center study in South Korea by Ji Hyun Yoon, Jae Hui Kim, Chul Gu Kim, Jong Woo Kim

    Published 2023-06-01
    Get full text
    Article
  4. 4
    Long-Term Outcomes of Switching from Fixed-Dose to As-Needed Regimen for Treating Submacular Hemorrhage Secondary to Polypoidal Choroidal Vasculopathy

    Long-Term Outcomes of Switching from Fixed-Dose to As-Needed Regimen for Treating Submacular Hemorrhage Secondary to Polypoidal Choroidal Vasculopathy by Jae Hui Kim, Jong Woo Kim, Chul Gu Kim, Dong Won Lee

    Published 2020-08-01
    Get full text
    Article
  5. 5
    Long-Term Treatment Outcomes in Type 3 Neovascularization: Focus on the Difference in Outcomes between Geographic Atrophy and Fibrotic Scarring

    Long-Term Treatment Outcomes in Type 3 Neovascularization: Focus on the Difference in Outcomes between Geographic Atrophy and Fibrotic Scarring by Jae Hui Kim, Jong Woo Kim, Chul Gu Kim, Dong Won Lee

    Published 2020-04-01
    Get full text
    Article
  6. 6
    Short-Term Outcomes of Switching to Ranibizumab in Polypoidal Choroidal Vasculopathy Resistant to Aflibercept Therapy

    Short-Term Outcomes of Switching to Ranibizumab in Polypoidal Choroidal Vasculopathy Resistant to Aflibercept Therapy by Young-Joon Jeon, Jae-Hui Kim, Jong-Woo Kim, Chul-Gu Kim

    Published 2021-12-01
    Get full text
    Article
  7. 7
    Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab

    Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab by Seul Gi Yoo, Jae Hui Kim, Tae Gon Lee, Chul Gu Kim, Jong Woo Kim

    Published 2015-01-01
    Get full text
    Article
  8. 8
    Abrupt visual loss during anti-vascular endothelial growth factor treatment for type 3 neovascularization

    Abrupt visual loss during anti-vascular endothelial growth factor treatment for type 3 neovascularization by Jae Hui Kim, Young Suk Chang, Jong Woo Kim, Chul Gu Kim, Dong Won Lee

    Published 2019-03-01
    Get full text
    Article
  9. 9
    Influence of bevacizumab therapy and intraretinal hemorrhage in long-term outcomes of hemorrhagic retinal arterial macroaneurysm

    Influence of bevacizumab therapy and intraretinal hemorrhage in long-term outcomes of hemorrhagic retinal arterial macroaneurysm by Jae Hui Kim, Jong Woo Kim, Chul Gu Kim, Young Ju Lew, Han Joo Cho

    Published 2021-07-01
    Get full text
    Article
  10. 10
    Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy

    Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy by Jihyun Yoon, Wontae Yoon, Seung kwan Na, Jihyun Lee, Chul Gu Kim, Jong Woo Kim, Han Joo Cho

    Published 2021-06-01
    Get full text
    Article
  11. 11
    Author Correction: Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy

    Author Correction: Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy by Jihyun Yoon, Wontae Yoon, Seung kwan Na, Jihyun Lee, Chul Gu Kim, Jong Woo Kim, Han Joo Cho

    Published 2021-09-01
    Get full text
    Article
  12. 12
    Prediction of anti-vascular endothelial growth factor agent-specific treatment outcomes in neovascular age-related macular degeneration using a generative adversarial network

    Prediction of anti-vascular endothelial growth factor agent-specific treatment outcomes in neovascular age-related macular degeneration using a generative adversarial network by Sehwan Moon, Youngsuk Lee, Jeongyoung Hwang, Chul Gu Kim, Jong Woo Kim, Won Tae Yoon, Jae Hui Kim

    Published 2023-04-01
    Get full text
    Article
  13. 13
    Comparison of treatment methods for submacular hemorrhage in neovascular age-related macular degeneration: conservative versus active surgical strategy

    Comparison of treatment methods for submacular hemorrhage in neovascular age-related macular degeneration: conservative versus active surgical strategy by Yongseok Mun, Kyu Hyung Park, Sang Jun Park, Han Joo Cho, Chul Gu Kim, Jong Woo Kim, Dong Geun Park, Min Sagong, Jae Hui Kim, Se Joon Woo

    Published 2022-09-01
    Get full text
    Article

Search Tools: